ViewPoints Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted Therapies
In an interview with PharmaShots, Dr. Malcolm Barratt-Johnson, Chief Medical Officer of Albert Labs shared his views on the psychedelic’s therapies, the companies’ business model and your plans for scaling the psychedelics therapies. Shots: Albert Labs will be the first psychedelics company to use an accelerated pathway, known as RWE studies, to swiftly provide access […]